9.4 Endocrine Crises: DKA, HHS, Thyroid Storm, Myxedema Coma & Adrenal Crisis

Diabetic Ketoacidosis (DKA) vs. Hyperosmolar Hyperglycemic State (HHS)

Diabetic emergencies represent a spectrum of insulin deficiency and counter-regulatory hormone excess (glucagon, catecholamines, cortisol, growth hormone). DKA is driven by absolute or near-absolute insulin deficiency, releasing the brake on lipolysis and hepatic ketogenesis. HHS is characterized by relative insulin deficiency sufficient to suppress hormone-sensitive lipase and prevent massive ketogenesis, but insufficient to stimulate peripheral glucose utilization, resulting in profound hyperglycemia, severe osmotic diuresis, and dehydration.

Diagnostic Comparison: DKA vs. HHS

Calculation of Effective Serum Osmolality

Urea diffuses freely across cell membranes and does not generate an osmotic driving force for intracellular water translocation. Therefore, effective osmolality (tonicity) omits BUN:

$\text{Effective } S_{\text{Osm}} = 2 \times [\text{Na}^+] + \frac{\text{Glucose (mg/dL)}}{18}$

• In HHS, the 2024 consensus threshold is effective osmolality $> 300\text{ mOsm/kg}$ (or total measured osmolality $> 320$); the degree of hyperosmolality, especially above about $320\text{ mOsm/kg}$, correlates with depressed consciousness. About one-third of patients have mixed DKA-HHS features and are treated as DKA.

---

Fluid, Insulin, and Electrolyte Resuscitation Protocols

Loading diagram...

Phase 1: Intravascular Volume Resuscitation

• Hour 1: Infuse $1000\text{ to }1500\text{ mL}$ (or $15-20\text{ mL/kg}$) of balanced crystalloid (Plasma-Lyte or Lactated Ringer's) or $0.9\%$ normal saline over the first hour to restore effective circulating arterial volume and renal perfusion. Balanced crystalloids reduce the incidence of hyperchloremic metabolic acidosis and accelerate time to DKA resolution compared to normal saline.
• Hours 2-24: Assess corrected sodium ($[\text{Na}^+] + 0.016 \times [\text{Glucose} - 100]$):
  • If corrected sodium is normal or elevated: switch to $0.45\%$ saline at $250\text{ to }500\text{ mL/h}$;
  • If corrected sodium is low: continue isotonic crystalloid at $250\text{ to }500\text{ mL/h}$.

Phase 2: Potassium Management Rules

Insulin drives potassium into skeletal muscle and hepatic cells. Initiating insulin before correcting hypokalemia causes precipitous cardiac arrest.

Phase 3: Continuous Insulin Infusion Kinetics

• Dosing: Continuous IV infusion of Regular Insulin at $0.1\text{ units/kg/h}$ (or a fixed rate of $0.14\text{ units/kg/h}$ without an initial bolus). An initial IV bolus ($0.1\text{ units/kg}$) is optional but not required.
• Target Glycemic Fall: Blood glucose should fall by $50\text{ to }75\text{ mg/dL/h}$. If glucose falls slower than $50\text{ mg/dL/h}$, verify intravenous line patency; if patent, double the insulin infusion rate hourly until the target fall rate is achieved.
• The Dextrose Transition Threshold:
  • When plasma glucose falls below $250\text{ mg/dL}$ in DKA or HHS (2024 consensus; older protocols used 200 mg/dL for DKA and 300 mg/dL for HHS), add $5\%$ to $10\%$ dextrose to the IV fluids while continuing insulin (usually reduced to about $0.05\text{ units/kg/h}$), keeping glucose about $150\text{ to }200\text{ mg/dL}$ in DKA and $200\text{ to }250\text{ mg/dL}$ in HHS until resolution. In HHS, fluids alone lower glucose substantially, so insulin is started at a lower rate (about $0.05\text{ units/kg/h}$) unless significant ketonemia is present.
  • Rationale: In DKA, insulin is required to turn off lipolysis and clear ketoacidemia, which takes significantly longer than normalizing blood glucose. Halting insulin when glucose drops to $200\text{ mg/dL}$ allows unabated ketoacid production to resume. Dextrose co-infusion prevents hypoglycemia while allowing insulin-mediated ketoacidosis clearance and preventing rapid osmotic shifts that provoke cerebral edema.

DKA Resolution and Subcutaneous Transition

Under the 2024 consensus, DKA is resolved when serum beta-hydroxybutyrate is $< 0.6\text{ mmol/L}$ together with venous $\text{pH} \ge 7.3$ or bicarbonate $\ge 18\text{ mmol/L}$ (glucose and anion gap are no longer resolution criteria). HHS is resolved when effective osmolality is $< 300\text{ mOsm/kg}$, glucose is $< 250\text{ mg/dL}$, urine output exceeds $0.5\text{ mL/kg/h}$, and cognition has returned to baseline.

---

Euglycemic DKA (euDKA) and SGLT2 Inhibitors

Euglycemic DKA is defined as severe ketoacidosis (anion gap metabolic acidosis with elevated serum beta-hydroxybutyrate $\ge 3.0\text{ mmol/L}$ and venous $\text{pH} \le 7.30$) presenting with normal or near-normal blood glucose ($< 250\text{ mg/dL}$, frequently $150-200\text{ mg/dL}$).

Pathophysiological Mechanism

• SGLT2 Inhibitors (Empagliflozin, Dapagliflozin, Canagliflozin): Block the sodium-glucose cotransporter-2 in the early proximal renal tubule, inducing constant, high-volume glucosuria ($50-100\text{ g/day}$). Glucosuria lowers circulating blood glucose without requiring insulin.
• The Ketogenic Shift: Depressed blood glucose decreases pancreatic beta-cell insulin secretion and stimulates alpha-cell glucagon release. The resulting low insulin-to-glucagon ratio activates adipose tissue hormone-sensitive lipase, unleashing a flood of free fatty acids into hepatic mitochondria. There, carnitine palmitoyltransferase-1 (CPT-1) channels fatty acids into beta-oxidation and massive synthesis of beta-hydroxybutyrate and acetoacetate.
• Clinical Pitfall: Clinicians fail to order ketones or blood gases because "the glucose is not high." euDKA is triggered by physiologic stressors (surgery, sepsis, trauma, acute MI, prolonged fasting) in patients taking SGLT2 inhibitors.
• Management: Immediately discontinue the SGLT2 inhibitor. euDKA requires the same insulin infusion protocol as hyperglycemic DKA, but dextrose (D5W or D10W) must be initiated concurrently from the very beginning of insulin therapy to support carbohydrate oxidation while insulin halts ketoacidosis.

---

Thyroid Storm: Burch-Wartofsky Criteria and Sequential Pharmacotherapy

Thyroid storm is a hypermetabolic, decompensated medical crisis triggered by excessive circulating thyroid hormone ($T_3/T_4$) combined with massive adrenergic hypersensitivity, often precipitated by systemic infection, surgery, non-compliance, trauma, or iodinated radiocontrast in patients with pre-existing thyrotoxicosis.

Diagnostic Stratification: Burch-Wartofsky Point Scale (BWPS)

The BWPS assigns points across six clinical domains: thermoregulatory dysfunction (temperature up to 30 pts), central nervous system agitation/delirium/coma (up to 30 pts), gastrointestinal-hepatic dysfunction (diarrhea/jaundice up to 20 pts), cardiovascular tachycardia (up to 25 pts), congestive heart failure (up to 15 pts), atrial fibrillation (10 pts), and precipitating event history (10 pts):

• BWPS $\ge 45$: Highly suggestive of Thyroid Storm (mandates immediate ICU protocol therapy);
• BWPS $25-44$: Impending thyroid storm;
• BWPS $< 25$: Thyroid storm unlikely.

Strict Pharmacologic Sequencing Protocol

Therapy must follow an unvarying, rigid sequence. Violating the timing sequence can precipitate fatal worsening of thyrotoxicosis:

Loading diagram...

---

Myxedema Coma: Pathophysiology and Emergency Resuscitation

Myxedema coma is life-threatening, end-stage hypothyroidism characterized by multi-system organ slowdown, severe hypothermia, and neuropsychiatric depression. Despite its name, patients need not be in an absolute vegetative coma; profound lethargy, stupor, or delirium in an elderly patient during winter months is diagnostic.

Clinical Tetrad of Myxedema Coma

1. Severe Hypothermia: Core body temperature frequently $< 35.5^\circ\text{C}$ ($< 95^\circ\text{F}$), often as low as $28-32^\circ\text{C}$. Shivering is absent due to profound metabolic depression.
2. Altered Mental Status: Stupor, apathy, hallucinations ("myxedema madness"), coma.
3. Hypoventilation and Hypercapnic Respiratory Failure: Depressed hypoxic and hypercapnic central ventilatory drive, combined with diaphragmatic weakness and upper airway obstruction from macroglossia and myxedematous vocal cord edema. Frequently requires early endotracheal intubation.
4. Cardiovascular Collapse & Severe Bradycardia: Decreased cardiac output, marked sinus bradycardia, low-voltage QRS, flattened/inverted T waves, pericardial effusion, and refractory hypotension.

• Classic Laboratory Hallmarks: Profound hypotonic hyponatremia (impaired free water clearance via non-osmotic ADH release), hypoglycemia, elevated creatine kinase (CK), and elevated TSH with low or undetectable free $T_4$.

Emergency Management Protocol

1. Step 1: Immediate Glucocorticoid Administration:
   • Draw baseline random cortisol and ACTH;
   • Administer Hydrocortisone $100\text{ mg}$ IV bolus, followed by $100\text{ mg}$ IV every 8 hours (or continuous infusion of $200\text{ mg/24h}$).
2. Step 2: Thyroid Hormone Replacement:
   • Intravenous Levothyroxine ($T_4$): Loading dose of $200\text{ to }400\ \mu\text{g}$ IV slow bolus, followed by a daily maintenance dose of $1.2\ \mu\text{g/kg/day}$ IV (use lower end of dosing in elderly patients or those with known coronary artery disease to avoid precipitating myocardial infarction or fatal ventricular arrhythmias).
   • Intravenous Liothyronine ($T_3$): Co-administration of IV $T_3$ is recommended because 5'-monodeiodinase activity (converting $T_4$ to active $T_3$) is severely impaired in critical illness. Administer $5\text{ to }20\ \mu\text{g}$ IV loading dose, followed by $2.5\text{ to }10\ \mu\text{g}$ IV every 8 hours until clinical improvement occurs and oral intake is restored.
3. Step 3: Passive External Rewarming:
   • Use warm blankets and heated ambient air. Avoid active aggressive external rewarming (such as heating pads or forced-air warmers set to high), as sudden peripheral cutaneous vasodilation shifts blood away from the core, precipitating fatal refractory distributive shock.
4. Step 4: Fluid Management:
   • Avoid hypotonic maintenance fluids; manage severe hyponatremia with water restriction and cautious $3\%$ hypertonic saline if seizures or brainstem displacement occur.

---

Acute Adrenal Crisis in the ICU

Acute adrenal crisis represents a critical lack of circulating glucocorticoids and mineralocorticoids relative to cellular demand during acute physiological stress.

Etiologic Categories

• Primary Adrenal Insufficiency (Addisonian Crisis): Destruction of the adrenal cortex. Causes include autoimmune adrenalitis, bilateral adrenal hemorrhage in severe sepsis (Waterhouse-Friderichsen syndrome classically secondary to Neisseria meningitidis or Streptococcus pneumoniae), bilateral adrenal vein thrombosis in antiphospholipid syndrome (APS), or systemic fungal/mycobacterial infections. Involves both glucocorticoid and mineralocorticoid deficiency.
• Secondary / Tertiary Adrenal Insufficiency: Pituitary or hypothalamic failure, or abrupt cessation of chronic exogenous corticosteroid therapy (suppressed hypothalamic-pituitary-adrenal [HPA] axis). Mineralocorticoid synthesis (governed by the renin-angiotensin-aldosterone system) remains largely intact; only glucocorticoids are deficient.

Diagnostic Presentation in the ICU

• Refractory Vasodilatory Shock: Hypotension unresponsive to aggressive fluid resuscitation and high-dose vasopressor infusions (norepinephrine, vasopressin). Cortisol is required for adrenergic receptor expression and vascular smooth muscle sensitivity to catecholamines; in its absence, systemic vascular resistance (SVR) remains profoundly depressed.
• Associated Manifestations: Severe abdominal pain, nausea, vomiting (frequently misdiagnosed as acute surgical abdomen), fever, hypoglycemia, and in primary disease, hyperkalemia, hyponatremia, and hyperpigmentation.

Diagnostic Evaluation and Resuscitation Protocol

• Cosyntropin Stimulation Test: Administer synthetic ACTH ($250\ \mu\text{g}$ IV). Measure serum cortisol at baseline, 30 minutes, and 60 minutes post-dose. A normal, intact adrenal response produces a peak cortisol $\ge 18\ \mu\text{g/dL}$ with older polyclonal immunoassays; with newer monoclonal immunoassays and LC-MS/MS the cutoff is lower (about $14\text{ to }15\ \mu\text{g/dL}$), so interpret against the laboratory's assay. However, diagnostic testing must NEVER delay life-saving steroid administration in suspected crisis!
• Emergency Treatment Protocol:
  1. Immediate Hydrocortisone: Administer Hydrocortisone $100\text{ mg}$ IV bolus, followed by $200\text{ mg}$ per 24 hours (administered as $50\text{ mg}$ IV every 6 hours or a continuous infusion of $8.3\text{ mg/h}$).
  2. Steroid Selection if Testing Pending: If the clinical team insists on performing an immediate Cosyntropin stimulation test before steroid administration, Dexamethasone $4\text{ mg}$ IV may be substituted. Dexamethasone is a potent glucocorticoid that does not cross-react with the serum cortisol radioimmunoassay, allowing uninhibited testing. (Hydrocortisone cross-reacts directly and invalidates subsequent cortisol assays).
  3. Fluid and Glucose Resuscitation: Infuse $5\%$ Dextrose in $0.9\%$ Normal Saline (D5NS) to aggressively reverse hypovolemia, correct hyponatremia, and treat life-threatening hypoglycemia.
  4. Role of Mineralocorticoids: Fludrocortisone is NOT needed in acute adrenal crisis. At hydrocortisone doses $\ge 100\text{ mg/day}$, hydrocortisone exhibits massive cross-activation of mineralocorticoid receptors that saturates renal tubular transport. Fludrocortisone ($0.05-0.1\text{ mg/day}$ PO) is initiated only later, when the hydrocortisone dose is tapered below $50\text{ mg/day}$.